U.S. Supreme Court slaps big pharma for paying generic makers to delay lower cost medications
Ruled 5-3 that agreements between the makers of name-brand and generic drugs to delay the generics' availability can be illegal, an outcome cheered by consumer groups.
LATEST NEW HAMPSHIRE ANGLE
Charlie Rose talks to Ex-GOP Sen. Judd Gregg
NH man finds huge, edible mushroom
What's open / what's closed on Thanksgiving
Big tipper stops for lunch